Our findings support the hypothesis that CNS tumors with FOXR2 overexpression exhibit diverse histopathologic, molecular, and clinical features, indicating that FOXR2 alterations are not pathognomonic of CNS NB-FOXR2. The gene discussed is FOXR2; the disease is central nervous system neoplasm.